Anthem Biosciences IPO listing was in line with the Street estimates as indicated by the grey market premium (GMP). Anthem Biosciences IPO GMP today ahead of the listing and analysts had signalled a ...

Anthem Biosciences IPO listing date is today. Ahead of the listing, Anthem Biosciences IPO GMP today and analysts signal a strong debut of shares in the Indian stock market today.

The initial public offer of Anthem Biosciences Ltd received a good response from investors and was subscribed 63.86 times on the closing day of bidding on Wednesday.

AM, Anthem Biosciences share price on the BSE was trading at Rs. 730.70, up Rs. 7.60 or 1.05% from the listing price and a 28.19% gain over the issue price. On the NSE, the stock was quoted at Rs. 730 ...

This strong response from different investor categories highlights the market's confidence in ABL's potential as a publicly listed company. Anthem Biosciences is an innovation-driven, ...

Anthem Biosciences IPO GMP stands at ₹143, hinting at a strong listing around ₹713. Check latest grey market updates, expected price, and allotment status.

Considering Anthem Biosciences IPO GMP today, the estimated listing price of Anthem Biosciences shares would be ₹ 714 apiece, which is at a 25.26% premium to the IPO price of ₹ 570 per share.

Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, as investors bet on its growth prospects as global big pharma turns to ...

Anthem Biosciences Ltd. made a stellar debut in the secondary market with a premium of 27% over its IPO price. The scrip was listed at Rs 723.05B apiece on the NSE and Rs 723.1 on the BSE. The issue ...

Anthem Biosciences IPO GMP today signals that the estimated Anthem Biosciences share listing price would be ₹ 747 apiece, which is at a 31.05% premium to the IPO price of ₹ 570 per share.